The effect of rigvir, an immunomodulator of the viral origin, on cell-mediated immunity was studied in patients with skin malignant melanoma. Rosette formation and monoclonal antibody techniques were used to measure blood immunocompetent cell levels in patients with the above pathology, cases of benign skin tumors and healthy subjects. Rigvir was shown to influence natural resistance by raising blood monocyte and large granule-containing lymphocyte levels. It potentiated recruitment of pre-T-lymphocytes and young active T-lymphocytes to the peripheral blood.

Download full-text PDF

Source

Publication Analysis

Top Keywords

malignant melanoma
8
[the cellular
4
cellular immunity
4
immunity indices
4
indices patients
4
patients malignant
4
melanoma viral
4
viral immunomodulator
4
immunomodulator rigvir]
4
rigvir] rigvir
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!